DKSH Holding has acquired Terra Firma, a leading distributor of specialty chemicals in North America. With this acquisition, DKSH expands its performance materials business unit platform to the US and Canada. The transaction is an
Tags :Frank Gerhard
Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, has completed a USD 4,2 million equity financing. The allosteric modulation company Addex has entered into a definitive agreement with Armistice Capital, a
BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access
Dufry has announced that it has entered into an agreement with the Italian company Edizione to collaborate with Autogrill to create a new integrated global travel experience. The combined company will serve more than 2.3 billion
DKSH Holding has announced the acquisition of Swiss Refarmed Group, strengthening its capabilities in the life sciences. Through the acquisition, DKSH Business Unit Performance Materials, the leading global distributor of innovative pharmaceutical ingredients synthesis and
Clariant has completed the sale of its pigments business to a consortium of Heubach Group and SK Capital Partners and reinvested approx. CHF 115 million of the purchase price to become a 20% shareholder alongside Heubach Group
Allosteric modulation company Addex Therapeutics has entered into a definitive agreement with Armistice Capital, a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares («ADSs») at
Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round
Private equity healthcare fund ArchiMed announced the acquisition of Stragen Pharma from its founder and several shareholders, through its EUR 1 billion MED Platform I fund. The advisors Walder Wyss acted as legal counsel
Private equity firm, Naxicap Partners has closed the acquisition of a majority stake in Groupe 3R (Réseau Radiologique Romand), a Swiss radiological network created by Dr. Dominique Fournier. The advisors Python advised Naxicap Partners
